EMAIL THIS PAGE TO A FRIEND

COPD

Sirtuin 1 Activator SRT1720 Protects Against Lung Injury via Reduction of Type II Alveolar Epithelial Cells Apoptosis in Emphysema.


PMID 25415045

Abstract

In chronic obstructive pulmonary disease (COPD), two major pathological changes that occur are the loss of alveolar structure and airspace enlargement. Type II alveolar epithelial cells (AECII) play a vital role in maintaining alveolar homeostasis and lung tissue repair. Sirtuin 1 (SIRT1), a NAD(+)-dependent histone deacetylase, regulates many pathophysiological processes including inflammation, apoptosis, cellular senescence and stress resistance. The main aim of this study was to investigate whether SRT1720, a pharmacological SIRT1 activator, could protect against AECII apoptosis in rats with emphysema caused by cigarette smoke exposure and intratracheal lipopolysaccharide instillation in vivo. During the induction of emphysema in rats, administration of SRT1720 improved lung function including airway resistance and pulmonary dynamic compliance. SRT1720 treatment up-regulated the levels of surfactant protein (SP)A, SPC, SIRT1 and forkhead box O 3, increased SIRT1 activity, down-regulated the level of p53 and inhibited AECII apoptosis. Lung injury caused by emphysema was alleviated after SRT1720 treatment. SRT1720 could protect against AECII apoptosis in rats with emphysema and thus could be used in COPD treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB3700859 Anti-Rabbit IgG (Fc specific), highly cross adsorbed-Texas Red® antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700858 Anti-Rabbit IgG (Fc specific)-Texas Red® antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB4600015
Anti-Rabbit IgG (H+L), CF 350 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600021
Anti-Rabbit IgG (H+L), CF 405M antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600024
Anti-Rabbit IgG (H+L), CF 405S antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600044
Anti-Rabbit IgG (H+L), CF 488A antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600068
Anti-Rabbit IgG (H+L), CF 555 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600084
Anti-Rabbit IgG (H+L), CF 568 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600107
Anti-Rabbit IgG (H+L), CF 594 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600140
Anti-Rabbit IgG (H+L), CF 633 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600163
Anti-Rabbit IgG (H+L), CF 640R antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600184
Anti-Rabbit IgG (H+L), CF 647 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600193
Anti-Rabbit IgG (H+L), CF 660C antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600195
Anti-Rabbit IgG (H+L), CF 660R antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600212
Anti-Rabbit IgG (H+L), CF 750 antibody produced in goat, ~2 mg/mL, affinity isolated antibody
SAB4600223
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF350 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600406
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF350 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600389
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF488A antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600300
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF555 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600391
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF555 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600400
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF568 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600322
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF594 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600407
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF594 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600404
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF633 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600398
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF640R antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600399
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF640R antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600352
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF647 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600393
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF647 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600362
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF680 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4600395
Anti-Rabbit IgG (H+L), F(ab′)2 fragment, CF680 antibody produced in goat, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution